Medication Safety

Giving intermittent intravenous infusions by gravity in adults

6 September 2024Infusion by gravity is not the preferred method of administration, but may be necessary in some circumstances. Ensure a risk assessment is undertaken.

Ensuring time critical use of rasburicase

9 September 2025Timely use of rasburicase for treatment of tumour lysis syndrome is essential. Mitigation strategies can minimise harm associated with delayed therapy.

Ensuring the safe use of amphotericin B injection

25 November 2025Amphotericin B liposomal products and Fungizone are not interchangeable. Take action to prevent death caused by inadvertent mis-selection

Embedding the safer use of insulin

6 May 2026Implementation of national safety standards, alerts and guidance can help reduce preventable harm from insulin use.

Embedding medication safety improvement within an organisation

30 April 2026The Patient Safety Incident Response Framework (PSIRF) can support effective prioritisation and delivery of medication safety improvements.

Developing opioid safety across a system

2 June 2025Strategies and signposting to support safer use of opioids for chronic, non-cancer pain.

Developing insulin safety across a system

6 May 2026Strategies, signposting and initiatives to support healthcare professionals in delivering insulin safety improvements.

Developing direct oral anticoagulant safety across a system

6 July 2026Strategies and signposting to support safer use of direct oral anticoagulants (DOACs).

Developing Medication Safety Across The System (MSATS)

4 June 2026Medication Safety Across the System (MSATS) provides resources and networking to inspire and equip individuals in promoting the safe use of medicines.

Defining time critical medicines

18 December 2025A resource to support healthcare professionals in defining time critical medicines to support safety improvements.